News Archives - QualityStocks

FridayJun 12, 2026 9:00 am

Future of Mining Australia 2026 – Shaping the Next Era of Mining

Date: June 16-17, 2026 Venue: Crown Perth, Australia Future of Mining Australia 2026 will bring together industry leaders, innovators, policymakers, and technology providers, in Perth, Australia, June 16–17, 2026, to discuss the next era of Mining. The event is positioned around the theme “Mining Smarter, Mining Better”. With the growing pressure to deliver more minerals and operate more efficiently, while maintaining a sustainable approach, the event focuses on practical solutions for enhancing efficiency, resilience, and long-term sustainability in mining operations. Approximately 1,800 attendees are expected to attend this highly anticipated event, featuring over 900 mining executives, 100+ expert speakers, and…

ThursdayJun 11, 2026 9:45 am

MindWave Innovations Inc. (NYSE American: APUS) Builds Institutional Bridge for Bitcoin Treasury Adoption

The corporate DAT movement has gained visibility as public companies increasingly treat bitcoin and other digital assets as strategic balance-sheet holdings rather than short-term speculative instruments MindWave provides a secure and compliant gateway to digital assets through insured custody solutions, AI-enabled yield strategies and transparent reporting systems. The company’s institutional positioning is strengthened by its live bitcoin treasury activity. As bitcoin moves deeper into corporate finance, the central question for many companies is no longer whether digital assets belong on the balance sheet but rather how they can be held, reported and deployed responsibly. MindWave Innovations (NYSE American: APUS) is…

ThursdayJun 11, 2026 9:00 am

VERAXA Biotech AG (NASDAQ: VRXA) Is ‘One to Watch’

VERAXA is advancing a diversified oncology pipeline spanning monoclonal antibodies, antibody-drug conjugates, bispecific ADCs and proprietary BiTAC-based therapeutic formats across multiple cancer indications. The company’s proprietary BiTAC platform is designed to conditionally activate therapeutic activity at tumor sites, with the goal of improving target specificity while reducing off-tumor toxicity. Through its focus on ADCs and TCEs, VERAXA is positioned within two rapidly growing segments of the global oncology therapeutics market. Via selected partnerships, VERAXA aims to contribute value to developments in complementary therapeutic sectors such as radioimmunoconjugates (“RICs”) and antibody-oligonucleotide conjugates (“AOCs”). VERAXA Biotech has successfully concluded a business combination…

WednesdayJun 10, 2026 9:00 am

Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) Is ‘One to Watch’

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising. Onco-Innovations is developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target DNA repair pathways involved in cancer survival and treatment resistance. The company is positioning itself as a leader in the emerging PNKP inhibitor class, a segment of the broader DNA Damage Response therapy market that is distinct from established PARP inhibitor therapies. Five patents protect the company’s PNKP inhibitor technology, nanoparticle delivery platform and related applications, supporting its intellectual property position as development advances. Through its wholly owned subsidiary Inka Health, Onco-Innovations has…

MondayJun 08, 2026 9:45 am

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Proprietary Therapy for Multiple Sclerosis Treatment

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma’s LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or restoring myelin integrity that affects the loss of mobility or control of a person’s body. The company announced the completion of phase 1 clinical studies involving healthy volunteers, reporting that the therapy demonstrated a favorable safety profile and was generally well tolerated. Quantum BioPharma reached a significant milestone in April 2026 when it announced the submission of an Investigational New Drug application to the U.S. Food…

MondayJun 08, 2026 9:00 am

Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) Is ‘One to Watch’

Disseminated on behalf of Redwood AI Corp. (CSE: AIRX) (OTCQB: RDWCF) and may include paid advertising. Redwood AI is developing a proprietary AI platform designed to support drug discovery, synthesis planning, and chemical analysis across pharmaceutical, public safety, defense, and industrial-related markets. The company is positioned across multiple large global market opportunities, including pharmaceutical development, defense-related chemical intelligence, AI-assisted drug discovery, and CDMO infrastructure applications. Reactosphere combines synthesis planning, optimization workflows, sourcing intelligence, and chemical analysis capabilities within a single AI-driven platform. Redwood AI is advancing its AI-powered chemistry platform through research collaborations and government-supported initiatives involving organizations including UBC,…

FridayJun 05, 2026 11:15 am

Bitcoin as a Corporate Treasury Asset: How MindWave Innovations Inc. (NYSE American: APUS) Is Redefining Institutional Yield Infrastructure

MindWave Innovations recently advanced its Bitcoin treasury strategy with up to $100M PIPE and activation of 1,000 BTC, accelerating institutional adoption of AI-driven digital asset infrastructure The company operates at the intersection of insured custody, AI yield engines, and board-governed segregated treasury structures These developments reinforce MindWave’s mission: providing institutional-grade treasury infrastructure for the digital asset economy MindWave Innovations (NYSE American: APUS) is strategically positioning itself at the forefront of a structural shift in corporate finance: the transition from static treasury holdings to intelligent, yield-generating digital asset infrastructure. As companies increasingly follow the path pioneered by MicroStrategy and newer institutional adopters, the demand for compliant, secure, and yield-optimized…

FridayJun 05, 2026 10:30 am

Oncotelic Therapeutics Inc. (OTLC) Combines Nanomedicine, AI, and Robotics to Advance Precision Oncology and Rare Disease Innovation

OTLC continues to advance its Deciparticle nanomedicine platform, with expanding international development initiatives supporting future therapeutic and commercial opportunities. The company's PDAOAI ecosystem now incorporates 28 million scientific abstracts and is being deployed into real-world pharmaceutical automation applications through TechForce Robotics. The company is leveraging AI, nanomedicine, and automation to accelerate therapies for cancer and rare diseases. Oncotelic Therapeutics (OTCQB: OTLC) is strategically placing itself at the nexus of precision oncology, advanced automation, and artificial intelligence. Through its PDAOAI artificial intelligence ecosystem, Deciparticle(TM) nanomedicine platform, and emerging robotics initiatives, the company is quickly building an integrated technology portfolio built to…

FridayJun 05, 2026 9:45 am

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Targets Growing Need for Non-Invasive Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics is developing AI-powered voice analysis technology designed to detect drug and alcohol impairment from short speech samples. The platform analyzes more than 140 acoustic markers and has been trained on a dataset exceeding 50 million data points. Mining operations in South America represent the company’s initial commercial focus, where workforce safety and high-volume screening requirements create operational challenges. Potential applications extend beyond mining into aviation, construction, law enforcement, call centers, transportation, and mental health settings. The global alcohol and drug testing devices…

FridayJun 05, 2026 9:00 am

Numa Numa Resources Inc. Committed to Advancing Bougainville Infrastructure Alongside Mining Development

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements. Today many mining projects are designed with a wider development mandate, recognizing that infrastructure can generate benefits extending well beyond the life of a mine. Numa Numa Resources has positioned infrastructure development as a central component of its strategy. The company’s infrastructure efforts are occurring alongside agreements with landowners connected to the Panguna resource area. Modern mining projects are no longer judged solely by the minerals they produce. Increasingly, companies are being evaluated on the roads they build, the power systems they create and the long-term economic…

Site Search

Company Search

Category: News